Cost-Effectiveness Thresholds: Economic and ethical issues
C. Pritchard and
Nancy Devlin ()
in Monographs from Office of Health Economics
The papers in this book are based on the proceedings of a workshop jointly organised by the OHE and the King's Fund and hosted by the King's Fund on 1 March 2002. The authors of the papers that make up this book were asked to address a specific question - 'Ought NICE to have a threshold incremental cost-effectiveness ratio (ICER)?' -with an implicit second question 'Should the threshold be explicit?' Since its inception, NICE (the National Institute for Clinical Excellence) has made a very firm and public commitment to maximise the openness and transparency of its criteria and the processes through which they are developed and applied. It therefore seems uncontroversial that any such threshold ought to be explicit
Keywords: Economics; of; Health; Technology; Assessment (search for similar items in EconPapers)
JEL-codes: I1 (search for similar items in EconPapers)
References: View complete reference list from CitEc
Citations: View citations in EconPapers (13) Track citations by RSS feed
Downloads: (external link)
https://www.ohe.org/system/files/private/publicati ... Thresholds_Towse.pdf (application/pdf)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:ohe:monogr:000473
Access Statistics for this book
More books in Monographs from Office of Health Economics Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ().